This is the authors' abstract. We don't add key points for this paper.
Introduction: Recurrent pregnancy loss (RPL) is defined as two or three consecutive miscarriages and requires further investigations and management. Many causes such as genetic factors, immunological disturbances, anatomical abnormalities, and thrombophilia have been linked to cases of RPL. Multiple studies have investigated the outcomes of different treatment including Intravenous immunoglobulin (IVIG). Case Report: We are presenting a case of woman with 23 consecutive pregnancy loss who was treated with IVIG during her pregnancy. The patient delivered at 34 weeks with no complications and discharged from the hospital in stable condition. Conclusion: Further studies need to be conducted to establish the role of IVIG infusion in the treatment of patient with recurrent pregnancy loss.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Alblewi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: